ArticlePloS one2016

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.

Yasushi Honda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.